Library

N-metilciklazodonas

N-Methyl-Cyclazodone is approximately 4-6 times more potent than its parent compound cyclazodone. Human pharmacological data are extremely limited; structurally related pemoline analogs have documented hepatotoxicity, warranting caution with chronic use. A 2022 case report documented severe toxicity requiring hospitalization after ~5g cumulative intake over 5 days. Prolonged wakefulness can obscure sleep debt and appetite suppression may lead to nutritional deficiencies. As a novel research chemical with minimal safety data, periodic liver enzyme monitoring and conservative dosing are strongly advised.

Also known as: Nmc, Ld 4202, N‑methyl‑cyclaz, NMCY

Classification

  • Chemical: Aminorex
  • Psychoactive: Nootropic
  • Psychoactive: Stimulant
  • Tag: Habit-Forming
  • Tag: Oxazolinone
  • Tag: Research-Chemical

Effects

  • Stimulation
  • Physical Euphoria
  • Increased Heart Rate
  • Pupil Dilation
  • Vasoconstriction
  • Increased Blood Pressure
  • Focus Enhancement
  • Wakefulness
  • Motivation Enhancement
  • Cognitive Euphoria
  • Anxiety
  • Time Distortion
  • Appetite Suppression
  • Increased Music Appreciation
  • Light Sensitivity
  • Bodily Control Enhancement
  • Increased Libido
  • Dehydration

Routes of Administration

Oral

Dosage

  • Threshold: 3 mg
  • Light: 5-8 mg
  • Common: 10-15 mg
  • Strong: 20-25 mg
  • Heavy: 30 mg+

Duration

  • Onset: 0.25-0.75 h
  • Comeup: 0.5-1 h
  • Peak: 2-5 h
  • Offset: 2-3 h
  • After Effects: 8-16 h
  • Total Duration: 6-10 h

Sublingual

Dosage

  • Threshold: 2 mg
  • Light: 4-6 mg
  • Common: 8-12 mg
  • Strong: 15-20 mg
  • Heavy: 25 mg+

Duration

  • Onset: 0.17-0.5 h
  • Comeup: 0.33-0.75 h
  • Peak: 2-5 h
  • Offset: 2-3 h
  • After Effects: 8-16 h
  • Total Duration: 6-10 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu

N-Methyl-Cyclazodone - DrugsPRO substancijos vadovas

N-Methyl-Cyclazodone: N-Methyl-Cyclazodone is approximately 4-6 times more potent than its parent compound cyclazodone. Human pharmacological data are extremely limited; structurally related pemoline analogs have documented hepatotoxicity, warranting caution with chronic use. A 2022 case report docu

Related pages